Holmusk - AI in Healthcare

展开查看详情

1. Singapore New York City Shanghai London Holmusk is a data science and health technology company dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. HOLMUSK’S VISION Mental health disorders remain the highest unmet medical need, surpassing cardiovascular disease, diabetes and cancer. Cumulative economic burden exceed 16 Trillion USD in direct and indirect costs. At Holmusk, we are addressing this To build the world's largest problem by building the world's largest Real-World Evidence (RWE) platform for Real-World Evidence mental health to deliver clinical and regulatory grade evidence to all major stakeholders of the healthcare ecosystem. (RWE) platform and enable a leapfrog-change in Holmusk’s proprietary technology is harnessed to analyze real-world data and drive data-driven medicine. In addition to Mental Health, our approaches are utilized research and the provision across other chronic metabolic diseases including diabetes, cardiovascular disease, of care through machine chronic kidney disease. Integrating this work, we generate evidence for even learning, deep learning deeper insights, with the goal of developing a system-wide integrated care model between mental and chronic health. We make access to RWE a reality of today, and digital tools. rather than a dream of tomorrow. LE ADERSHIP NOTABLE AWARDS & RECOGNITIONS World Economic Forum 2019 Technology Pioneer Nawal Roy Founder & CEO Innovations in Healthcare - 2020 Cohort of Innovators Resident of JLABS @NYC and @Shanghai Dr. Yau Teng Yan Chief Medical Officer Ping An Cloud Accelerator Company - 3rd Cohort Merck Diabetes Prevention Innovation Challenge, 2nd Sai Subramanian Prize Chief Technology Officer 4-time Winner, CrowdANALYTIX of Asia Actuarial Competition J&J QuickFire Challenge Finalist Joydeep Sarkar Chief Analytics Officer Bayer Grants4Apps Challenge Winner

2.KEY HOLMUSK METRICS EXPERT ADVISORS 50-persons 10.25 million USD Dr. Olivier Oullier strong, diverse team capital raised President, EMOTIV (including 10 PhDs) Dr. Amir Kalali MD 30+ 6 international Professor of Psychiatry, UCSD; Ex-global head, global clients/partners offices in 5 countries: Singapore IQVIA (three Fortune 500) (HQ), USA, China, Malyasia and United Kingdom Dr. Ranga Krishnan Dean, Rush Medical College Strong commercial CEO is member of the and institutional relationships: Steering Committee for Value Ministry of Health Singapore; Based Health Care at the Dr. Anand Tharmaratnam Singapore Health Services World Economic Forum (WEF) President, (SingHealth); Health Asia Pacific at IQVIA Promotion Board (HPB) Singapore; Duke University, USA; Duke-NUS, Singapore; Dr. John Rush Oxford University Professor Emeritus, Duke-NUS HOLMUSK PARTNERS

3. Recognized as 2019 World Economic Forum Technology Pioneer London New York Durham NC Shanghai Malaysia Singapore Office Client Raised >US$10M, raising 6 international offices in 5 countries: 50 person team 5 years old US$40M+ for Series A. Singapore (HQ) • USA • China (12 nationalities, 10 PhDs) Near break-even Malaysia • United Kingdom Building with the spirit of climbing Mount Everest Paul Valin climbed to the top of the Mt Everest, May 21 2018 at 7:00am www. h o lm u s k. com

4. 新加坡 纽约市 上海 伦敦 Holmusk是一家数据科学与医疗技术公 司,致力于建立客观证据,并将其作 为治疗精神健康和慢性疾病的核心实 用工具。 HOLMUSK的愿景 精神疾病仍然有着最高的未满足医疗需求,超过了心血管疾病、糖尿病和癌症。精神疾病 造成的直接和间接成本累计超过16万亿美元。Holmusk正在通过构建世界上最大的精神健 建立世界上最大的真实世界证 康真实世界证据(RWE)平台来解决此问题,旨在向医疗保健生态系统中的所有主要利益 相关方提供临床和监管用途的证据。 据(RWE)平台,并通过机器 Holmusk专有技术可用于分析真实世界数据并推动数据驱动的医学发展。除了精神健康 学习、深度学习和数字工具实 外,我们的技术还可用于其他慢性代谢性疾病领域,包括糖尿病、心血管疾病、慢性肾脏 疾病。通过整合这项工作,我们为更深入的洞见提供了证据,目的是开发一种用于精神疾 现研究和护理服务的“跳跃式” 病和慢性疾病的全系统综合护理模型。Holmusk令RWE不再是梦。 变革 领导团队 获奖情况与荣誉资质 世界经济论坛2019年度“技术先 Nawal Roy 锋” 创始人兼首席执行官 医疗创新项目 - 2020年创新 者梯队成员 JLABS纽约和上海入驻企业 Joydeep Sarkar 首席分析官 平安云加速器第三期成员 默克糖尿病预防创新挑战赛 二等奖 Dr. Yau Teng Yan CrowdANALYTIX亚洲精算竞赛4次 首席医疗官 夺冠 强生QuickFire挑战赛决赛入围者 拜耳Grants4Apps挑战赛冠军 Sai Subramanian 首席技术官

5.HOLMUSK关键指标 专家顾问 50+ 人 筹集资金 3275万美元 Dr. John Rush 杜克-新加坡国立大 强大的、多元化的团队 学医学院荣誉教授 (包括10名博士) 在5个国家/地区【新加坡(总部)、 美国、中国、马来西亚和英国】设有 Dr. Olivier Oullier 30+ 6个国际办事处 EMOTIV总裁 全球客户/合作伙伴(三 次入选财富五百强) Dr. Amir Kalali MD 美国加利福尼亚大学圣地 CEO是世界经济论坛 亚哥分校精神病学教授, 艾昆纬前全球负责人 (WEF)基于价值的医疗保健指 强大的商业与机构关系: 导委员会成员 新加坡卫生部;新加坡卫生服 Dr. Ranga Krishnan Dean, 务(SingHealth);新加坡健 芝加哥拉什医学院院长 康促进委员会(HPB);美国 杜克大学;新加坡国立大学; 牛津大学 Dr. Anand Tharmaratnam 艾昆纬亚太区总裁 HOLMUSK合作伙伴 企业合作伙伴: 商业与研究合作伙伴: +25天使投资人

6. 荣膺世界经济论坛2019年 度“技术先锋” 伦敦 纽约 北卡罗来纳州 达勒姆 上海 马来西亚 新加坡 办事处 客户 在5个国家/地区【新加坡(总部)、美 5年发展历程 50+ 人的团队 筹集资金超过3200万美 国、中国、马来西亚和英国】设有6个国 (12种国籍,10位博士) 元。 际办事处 登珠峰,行将远 Paul Valin于2018年5月21日上 午7:00登上珠穆朗玛峰山顶 www.holmusk.com